KAREN GARRETT: Open Payments
NPI 1912071796 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 50 payments from 11 companies in 2025. Trend: 2023 $1,158 · 2024 $1,128 · 2025 $867
Food & beverage: $856Speaker / faculty: $11
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $497 |
| Novo Nordisk Inc | 4 | $110 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Lilly USA, LLC | 3 | $51 |
| Amgen Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| PFIZER INC. | 1 | $16 |
| Abbott Laboratories | 1 | $16 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
Products named: BOTOX, VRAYLAR, Wegovy, REXULTI, QULIPTA, Repatha, MOUNJARO, UBRELVY.
Industry payments across VA — which companies pay providers there.
